Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
A longitudinal cohort study was undertaken to compare the risk of cardiopulmonary outcomes in patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disease (COPD) using glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists) (1):
Study authors concluded:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.